9.83
price up icon0.20%   0.02
after-market Handel nachbörslich: 9.61 -0.22 -2.24%
loading

Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten

pulisher
Dec 08, 2025

Exit Recap: Will Sutro Biopharma Inc stock benefit from automationTrade Analysis Report & Low Risk Growth Stock Ideas - moha.gov.vn

Dec 08, 2025
pulisher
Dec 08, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Dec 08, 2025
pulisher
Dec 05, 2025

Sutro Biopharma (NASDAQ:STRO) Shares Gap DownWhat's Next? - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Will Sutro Biopharma Inc. (S09) stock sustain bullish trend into 20252025 Big Picture & AI Forecasted Stock Moves - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Can Sutro Biopharma Inc. stock sustain institutional interestJuly 2025 Institutional & Smart Investment Allocation Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Is Sutro Biopharma Inc. (S09) stock a top dividend aristocrat candidatePrice Action & Weekly Market Pulse Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Sutro Biopharma (NASDAQ:STRO) Shares Gap UpWhat's Next? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Is Sutro Biopharma Inc. (S09) stock attractive for growth fundsPortfolio Risk Report & Weekly Watchlist of Top Performers - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Sutro Biopharma doses first patients in phase 1 trial of STRO-004 - Investing.com Canada

Dec 04, 2025
pulisher
Dec 03, 2025

Sutro Biopharma (NASDAQ:STRO) Receives "Neutral" Rating from Wedbush - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma Announces Reverse Stock Split - TipRanks

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma (NASDAQ:STRO) Given Neutral Rating at Wedbush - Defense World

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma Initiates Dosing in Phase 1 TF-Expressing Cancer Study - MarketScreener

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma (STRO) Initiates Phase 1 Trial of STRO-004 for S - GuruFocus

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma announces first cohort of patients dosed in phase 1 trial of Stro-004 - marketscreener.com

Dec 03, 2025
pulisher
Dec 03, 2025

Are Smart Investors Making the Right Decision? Sutro Biopharma Inc (STRO) - setenews.com

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma doses first patients in phase 1 trial of STRO-004 By Investing.com - Investing.com South Africa

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma, Inc. Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in Tissue Factor - marketscreener.com

Dec 03, 2025
pulisher
Dec 03, 2025

What MACD trends signal for Sutro Biopharma Inc. (S09) stockWeekly Market Outlook & Low Volatility Stock Recommendations - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will Sutro Biopharma Inc. stock outperform value stocks2025 Market Overview & AI Enhanced Execution Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Sutro Biopharma falls as it announces 1-for-10 reverse stock split - MSN

Dec 03, 2025
pulisher
Dec 02, 2025

Why Sutro Biopharma Inc. stock is popular among millennials2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

How Sutro Biopharma Inc. stock reacts to inflationary pressures2025 Big Picture & High Return Trade Opportunity Guides - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

What earnings margins imply for Sutro Biopharma Inc. (S09) stockEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Sutro Biopharma announces 1-for-10 reverse stock split By Investing.com - au.investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

Sutro Biopharma stock falls after announcing 1-for-10 reverse split - Investing.com Canada

Dec 01, 2025
pulisher
Dec 01, 2025

Sutro Biopharma Sets 1-for-10 Reverse Stock Split - Nasdaq

Dec 01, 2025
pulisher
Dec 01, 2025

Sutro Biopharma Announces 1-for-10 Reverse Stock Split - The Manila Times

Dec 01, 2025
pulisher
Dec 01, 2025

Sutro Biopharma announces 1-for-10 reverse stock split - marketscreener.com

Dec 01, 2025
pulisher
Nov 30, 2025

Can Sutro Biopharma Inc. stock continue upward trendMarket Risk Analysis & Reliable Price Breakout Alerts - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 28, 2025

Holdings of Sutro Biopharma Inc (STRO) are aligned with the stars - Setenews

Nov 28, 2025
pulisher
Nov 27, 2025

Is Sutro Biopharma Inc. stock a contrarian buyQuarterly Investment Review & Risk Managed Trade Strategies - moha.gov.vn

Nov 27, 2025
pulisher
Nov 21, 2025

Can Sutro Biopharma Inc. stock reach $100 price target2025 Top Decliners & Daily Profit Focused Screening - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How reliable is Sutro Biopharma Inc. (S09) stock dividend growthMarket Sentiment Summary & AI Based Trade Execution Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Why Sutro Biopharma Inc. stock attracts global investorsSwing Trade & High Conviction Investment Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Statistical indicators supporting Sutro Biopharma Inc.’s strengthWeekly Investment Summary & Consistent Income Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Sutro Biopharma Inc. recover in the next quarterPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Applying big data sentiment scoring on Sutro Biopharma Inc.2025 Market WrapUp & Risk Controlled Daily Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Sutro Biopharma Inc. (S09) stock sustain institutional flowsWeekly Profit Recap & Verified Technical Trade Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Sutro Biopharma Inc. (S09) stock could break out in 2025 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Sutro Biopharma Inc. (S09) stock hold up in economic slowdown2025 Pullback Review & Risk Managed Trade Strategies - newser.com

Nov 19, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):